Janus Henderson Group PLC Has $5.03 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Janus Henderson Group PLC lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 8,460 shares of the biotechnology company’s stock after selling 133 shares during the period. Janus Henderson Group PLC’s holdings in Axon Enterprise were worth $5,026,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in AXON. Ritholtz Wealth Management lifted its stake in Axon Enterprise by 22.7% during the fourth quarter. Ritholtz Wealth Management now owns 616 shares of the biotechnology company’s stock worth $366,000 after purchasing an additional 114 shares during the last quarter. Merit Financial Group LLC boosted its holdings in Axon Enterprise by 19.0% in the fourth quarter. Merit Financial Group LLC now owns 5,579 shares of the biotechnology company’s stock valued at $3,316,000 after acquiring an additional 889 shares during the last quarter. Brooklyn Investment Group increased its position in shares of Axon Enterprise by 255.3% during the fourth quarter. Brooklyn Investment Group now owns 366 shares of the biotechnology company’s stock worth $218,000 after buying an additional 263 shares during the period. Premier Path Wealth Partners LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $222,000. Finally, HB Wealth Management LLC increased its holdings in Axon Enterprise by 5.0% in the fourth quarter. HB Wealth Management LLC now owns 1,441 shares of the biotechnology company’s stock worth $856,000 after purchasing an additional 68 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on AXON. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a “buy” rating in a report on Thursday, May 8th. Barclays boosted their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a “buy” rating in a research report on Wednesday, May 14th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average target price of $652.73.

Axon Enterprise Stock Up 0.7%

AXON opened at $733.18 on Monday. The firm has a market capitalization of $57.08 billion, a P/E ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a one year low of $273.52 and a one year high of $735.68. The company has a fifty day moving average price of $584.61 and a 200-day moving average price of $595.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. During the same period in the prior year, the company earned $1.15 EPS. The company’s quarterly revenue was up 31.3% compared to the same quarter last year. Equities research analysts expect that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This trade represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,764 shares of company stock worth $14,856,635 over the last three months. 4.40% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.